Home Cart Sign in  
Chemical Structure| 76822-21-4 Chemical Structure| 76822-21-4

Structure of Danshensu
CAS No.: 76822-21-4

Chemical Structure| 76822-21-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Danshensu, a herbal preparation used in traditional Chinese medicine, possesses potential antitumor and antiangiogenesis effects.

Synonyms: Salvianic acid A; Dan shen suan A

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Danshensu

CAS No. :76822-21-4
Formula : C9H10O5
M.W : 198.17
SMILES Code : O=C(O)[C@H](O)CC1=CC=C(O)C(O)=C1
Synonyms :
Salvianic acid A; Dan shen suan A
MDL No. :MFCD09038703
InChI Key :PAFLSMZLRSPALU-MRVPVSSYSA-N
Pubchem ID :11600642

Safety of Danshensu

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P261-P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
mouse chondrocytes 2.5, 5, 10 μM 24 h To evaluate the effect of DSS on IL-1β-induced inflammatory response, results showed that DSS inhibited the expression of IL-6, COX-2, TNF-α, and iNOS Mol Med. 2021 Jul 20;27(1):80
Human skeletal muscle cells 30 μM 24 h DSS significantly suppressed the mRNA expression of muscle atrophy-related factors (MuRF1, MAFbx, Myostatin, and FoxO3a). FASEB J. 2025 Jan 31;39(2):e70280
Mouse C2C12 myotubes 30 μM 24 h DSS significantly decreased the mRNA and protein expression of muscle atrophy-related factors (MuRF1, MAFbx, Myostatin, and FoxO3a) induced by DG and increased the diameter of C2C12 myotubes. FASEB J. 2025 Jan 31;39(2):e70280
Human peritoneal mesothelial cells (HMrSV5) 5 μg/mL 48 h To evaluate the effect of DSS-Exo and Exo on HMrSV5 cell fibrosis. Results showed that 5 μg/mL DSS-Exo treatment for 48 h significantly reduced mRNA levels of fibrosis markers (fibronectin and VEGFA) and increased E-cadherin levels. Stem Cell Res Ther. 2025 Feb 4;16(1):40
Human umbilical cord mesenchymal stem cells (MSCs) 200 μM 48 h To evaluate the effect of Danshensu preconditioning on MSCs viability and phenotypic stability. Results showed that 200 μM DSS treatment for 48 h significantly increased MSCs viability without affecting their phenotypic stability. Stem Cell Res Ther. 2025 Feb 4;16(1):40

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c mice SARS-CoV-2 S protein-induced acute lung inflammation model Intravenous injection 25, 50, 100 mg/kg Single intravenous injection Evaluate the protective effect of Danshensu on SARS-CoV-2 S protein-induced acute lung inflammation, results showed Danshensu dose-dependently alleviated pathological changes and inflammatory responses Acta Pharmacol Sin. 2022 Apr;43(4):771-780.
BALB/c mice SARS-CoV-2 S protein-induced acute lung inflammation model Oral administration 25, 50, 100 mg/kg Oral administration for 7 days Evaluate the protective effect of Danshensu on SARS-CoV-2 S protein-induced acute lung inflammation, results showed Danshensu dose-dependently alleviated pathological changes and inflammatory responses Acta Pharmacol Sin. 2022 Apr;43(4):771-780.
BALB/c mice SARS-CoV-2 S protein-induced acute lung inflammation model Intravenous injection or oral administration 25, 50, 100 mg/kg Single intravenous injection or oral administration for 7 consecutive days To evaluate the protective effect of Salvianolic acid C on SARS-CoV-2 S protein-induced acute lung inflammation, results showed significant alleviation of lung inflammation and pathological changes. Acta Pharmacol Sin. 2022 Apr;43(4):771-780.
C57BL/6 male mice Destabilization of the medial meniscus (DMM) model Intraperitoneal injection 40 mg/kg 8 weeks To evaluate the protective effect of DSS on OA progression, results showed that DSS significantly reduced DMM-induced cartilage OARSI score Mol Med. 2021 Jul 20;27(1):80
Female BLTW:CD1(ICR) mice Light-induced retinal degeneration model Oral gavage 100 mg/kg Twice daily for 40 days To investigate the protective effects of Danshensu on retinal tissues and functional vision. Results showed that Danshensu significantly prevented Müller cell gliosis and protected low spatial frequency-based visual contrast sensitivity function (VCSF) via the dopamine D1 receptor enhancement pathway. Nutrients. 2021 Mar 17;13(3):978
C57BL/6 mice D-galactose-induced accelerated aging model Intraperitoneal injection 50 mg/kg or 100 mg/kg Once daily for 4 weeks DSS improved muscle mass and physical performance (grip strength and hanging test) in DG-induced accelerated aging mice. FASEB J. 2025 Jan 31;39(2):e70280

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.05mL

1.01mL

0.50mL

25.23mL

5.05mL

2.52mL

50.46mL

10.09mL

5.05mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories